Page 7 of 9
Journal of the American Chemical Society
September 22, 2005. (d) Grandinetti, C. A.; Goldspiel, B. R. Pharmaꢀ
CONCLUSION
cotherapy 2007, 27, 1125. (e) Hilberg, F.; Roth, G. J.; Krssak, M.;
Kautschitsch, S.; Sommergruber, W.; TontschꢀGrunt, U.; GarinꢀChesa, P.;
Bader, G.; Zoephel, A.; Quant, J.; Heckel, A.; Rettig, W. J. Cancer Res.
2008, 68, 4774.
(2) (a) Trost, B. M.; Cramer, N.; Bernsmann, H. J. Am. Chem. Soc. 2007,
129, 3086. (b) Trost, B. M.; Cramer, N.; Silverman, S. M. J. Am. Chem.
Soc. 2007, 129, 12396. (c) Lin, S.; Danishefsky, S. J. Angew. Chem. Int.
Ed. 2011, 40, 1967.
1
2
3
4
5
6
7
8
In conclusion, we have developed a highly stereoselec-
tive method for the synthesis of 3-(chloromethylene)
oxindoles that takes advantage of an in situ-generated
vinyl PdII species. Excellent regio- and stereoselectivities
are observed for the alkyne chloropalladation step, which
is particularly rare for relatively unbiased, internal al-
kynes. High regioselectivities are achieved by virtue of the
reversibility of the cis-chloropalladation step. We demon-
strate that the vinyl chloride functionality in the products
can be functionalized through a variety of transfor-
mations, thus providing a divergent route to access a
library of medicinally-relevant scaffolds. Our calculations
support a mechanism involving a PdII/IV cycle, wherein
C−C bond reductive elimination is the driving force for
the reaction. Overall, carbamoyl chlorides are extremely
versatile intermediates in organic synthesis and their
application in Pd-catalyzed cross-couplings can provide
efficient entry to a range of nitrogen-containing heterocy-
cles.
(3) Selected examples: (a) Fielding, M. R.; Grigg, R.; Urch, C. J. Chem.
Commun. 2000, 2239. (b) Gabriele, B.; Salerno, G.; Veltri, L.; Costa, M.;
Massera, C. Eur. J. Org. Chem. 2001, 4607. (c) Teichert, A.; Jantos, K.;
Harms, K.; Studer, A. Org. Lett. 2004, 6, 3477. (d) Cheung, W. S.; Patch,
R. J.; Player, M. R. J. Org. Chem. 2005, 70, 3741. (e) Kamijo, S.; Sasaki,
Y.; Kanazawa, C.; Schüßeler, T.; Yamamoto, Y. Angew. Chem. Int. Ed.
2005, 44, 7718. (f) Shintani, R..; Yamagami, T.; Hayashi, T. Org. Lett.
2006, 8, 4799. (g) Miura, T.; Takahashi, Y.; Murakami, M. Org. Lett.
2007, 9, 5075. (h) Yang, T.ꢀM. Liu, G. J. Comb. Chem. 2007, 9, 86. (i)
Pinto, A.; Neuville, L.; Zhu, J. Angew. Chem. Int. Ed. 2007, 46, 3291. (j)
Park, J. H.; Kim, E.; Chung, Y. K. Org. Lett. 2008, 10, 4719. (k) Miura,
T.; Toyoshima, T.; Takahashi, Y.; Murakami, M. Org. Lett. 2009, 11,
2141.
(4) (a) Tang, S.; Yu, Q.ꢀF.; Peng, P.; Li, J.ꢀH.; Zhong, P.; Tang, R.ꢀY.
Org. Lett. 2007, 9, 3413. (b) Pedras, M. S. C.; Soresen, J. L.; Okanga, F.
I.; Zaharia, I. L. Bioorg. Med. Chem. 1999, 9, 3015. (c) Cantagrel, G.; de
CarnéꢀCarnavalet, B.; Meyer, C.; Cossy, J. Org. Lett. 2009, 11, 4262. (d)
Beccalli, E. M.; Marchesini, A. Tetrahedron 1994, 50, 12697. (e) Beccalli,
E. M.; Marchesini, A. Tetrahedron 1995, 51, 2353. (f) Sassatelli, M.;
Debiton, E.; Aboab, B.; Prudhomme, M.; Moreau, P. Eur. J. Med. Chem.
2006, 41, 709. (g) Le, C. M.; Hou, X.; Sperger, T.; Schoenebeck, F.;
Lautens, M. Angew. Chem. Int. Ed. 2015, 54, 15897.
(5) For reviews on C−X reductive elimination, see: (a) Petrone, D. A.; Le,
C. M.; Newman, S. G.; Lautens, M. Pd0ꢀCatalyzed Carboiodination: Early
Developments and Recent Advances. In New Trends in CrossꢀCoupling:
Theory and Application; Colacot, T. J., Ed.; RSC: Cambridge, 2015; pp
276. (b) Jiang, X.; Liu, H.; Gu, Z. Asian J. Org. Chem. 2012, 1, 16. (c)
Chen, C.; Tong, X. Org. Chem. Front. 2014, 1, 439. (d) Hartwig, J. F.
Inorg. Chem. 2007, 46, 1936. (e) Petrone, D. A.; Ye, J.; Lautens, M.
Chem. Rev. 2016, 116, 8003. For selected examples of Csp2−X reductive
elimination from PdII, see: (f) Newman, S. G.; Lautens, M. J. Am. Chem.
Soc. 2010, 132, 11416–11417. (g) Quesnel, J. S.; Arndtsen, B. A. J. Am.
Chem. Soc. 2013, 135, 16841. (h) Shen, X.; Hyde, A. M.; Buchwald, S. L.
J. Am. Chem. Soc. 2010, 132, 14076. (i) Roy, A. H.; Hartwig, J. F. J. Am.
Chem. Soc. 2001, 123, 1232. (j) Le, C. M.; Menzies, P. J. C.; Petrone, D.
A.; Lautens, M. Angew. Chem. Int. Ed. 2015, 54, 254. Also see ref 4g.
(6) (a) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285. (b) Tsuji, J.
Pd(0)ꢀ and Pd(II)ꢀCatalyzed Reactions of Alkynes and Benzynes. In
Palladium Reagents and Catalysts: New Perspectives for the 21st Century;
Tsuji, J., Ed.; John Wiley & Sons: West Sussex, 2005; pp 565ꢀ599.
(7) (a) Lu, X. PalladiumꢀCatalyzed Reaction via Halopalladation of πꢀ
Compounds. In Handbook of Organopalladium Chemistry for Organic
Synthesis; Negishi, E.ꢀI, Ed.; John Wiley & Sons: New York, 2002; pp
2267ꢀ2287 and references therein. (b) Ogawa, A. PalladiumꢀCatalyzed
SynꢀAddition Reactions of X−Pd Bonds (X=Group 15, 16, and 17 Eleꢀ
ments). In Handbook of Organopalladium Chemistry for Organic Syntheꢀ
sis; Negishi, E.ꢀI., Ed.; John Wiley & Sons: New York, 2002; pp 2841ꢀ
2849 and references therein. (c) Lu, X.; Zhu, G.; Wang, Z. Synlett 1998,
115 and references therein.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ASSOCIATED CONTENT
Supporting Information. Experimental procedures, spectral data
for all new compounds and crystallographic data (CIF). This
material is available free of charge via the Internet at
http://pubs.acs.org.”
AUTHOR INFORMATION
Corresponding Authors
*franziska.schoenebeck@rwthꢀaachen.de
*mlautens@chem.utoronto.ca
Present Addresses
†Department of Chemistry, University of Toronto, Davenport
Laboratories, 80 St. George St., Toronto M5S 3H6, Canada
‡Institute of Organic Chemistry, RWTH Aachen University,
Landoltweg 1, 52074 Aachen, Germany
Notes
The authors declare no competing financial interests.
ACKNOWLEDGMENT
We thank Alphora Inc., the Natural Sciences and Engineering
Research Council of Canada (NSERC) and the University of
Toronto (U of T) for financial support. M. L. (O.C.) thanks Canaꢀ
da Council for the Arts for a Killam Fellowship. C.M.L. thanks
NSERC for a postgraduate scholarship. We thank Renhe (Tony)
Li for the synthesis of starting materials, Dr. Alan J. Lough (U of
T) for obtaining the crystal structures of Zꢀ1v, 2z, and Z-1bc, and
Dr. Ivan Franzoni for helpful discussions. T.S. and F.S. thank the
RWTH Aachen, MIWF NRW and the Evonik Foundation (docꢀ
toral scholarship to T.S.) for funding.
(8) Selected examples with electronically or sterically biased alkynes: (a)
Ma, S.; Lu, X. J. Chem. Soc., Chem. Comun. 1990, 733. (b) Ma, S.; Lu, X.
J. Org. Chem. 1993, 58, 1245. (c) Huang, X.; Sun, A. J. Org. Chem. 2000,
65, 6561. (d) Huang, J.ꢀM.; Dong, Y.; Wang, X.ꢀX.; Luo, H.ꢀC. Chem.
Commun. 2010, 46, 1035. (e) Chen, X.; Kong, W.; Cai, H.; Kong, L.; Zhu,
G. Chem. Commun. 2011, 47, 2164. (f) Chen, D.; Cao, Y.; Yuan, Z.; Cai,
H.; Zheng, R.; Kong, L.; Zhu, G. J. Org. Chem. 2011, 76, 4071. (g) Cai,
H.; Yuan, Z.; Zhub, W.; Zhu, G. Chem. Commun. 2011, 47, 8682. (h) Lu,
Z.; Kong, W.; Yuan, Z.; Zhao, X.; Zhu, G. J. Org. Chem. 2011, 76, 8524.
(i) Peng, H.; Liu, G. Org. Lett. 2011, 13, 772.
REFERENCES
(1) (a) Davis, S. T.; Dickerson, S, H.; Frye, S. V.; Harris, P. A.; Hunter, R.
N.; Kuyper, L. F.; Lackey, K. E.; Luzzio, M. J.; Veal, J. M.; Walker, D. H.
Preparation of oxindoles as protein tyrosine kinase and protein serꢀ
ine/threonine kinase inhibitors. WO 9915500, April 1, 1999. (b) Hauf,
S.;Cole, R. W.; LaTerra, S.; Zimmer, C.; Schnapp, G.; Walter, R.; Heckel,
A.; van Meel, J.; Rieder, C. L.; Peters, J.ꢀM. J. Cell Biol. 2003, 161, 281.
(c) Heckel, A.; Roth, G. J.; Kley, J.; Hoerer, S.; Uphues, I. Preparation of
alkyl 5ꢀacylindolinones as inhibitors of GSKꢀ3. WO2005087727 A1,
(9) Select examples with aldehydes: (a) Larock, R. C.; Doty, M. J. J. Org.
Chem. 1993, 58, 4579. (b) Gevorgyan, V.; Quan, L.ꢀG.; Yamamoto, Y.
Tetrahedron Lett. 1999, 40, 4089. (c) ÁlvarezꢀBercedo, P.; FloresꢀGaspar,
A.; Correa, A.; Martin, R. J. Am. Chem. Soc. 2010, 132, 466. (d) Solé, D.;
Mariani, F.; Fernández, I. Adv. Synth. Catal. 2014, 356, 3237. (e) Zhao,
L.; Lu, X. Angew. Chem. Int. Ed. 2002, 41, 4343.
ACS Paragon Plus Environment